187 related articles for article (PubMed ID: 9847366)
21. A tripartite HIV-1 tat-env-rev fusion protein.
Salfeld J; Göttlinger HG; Sia RA; Park RE; Sodroski JG; Haseltine WA
EMBO J; 1990 Mar; 9(3):965-70. PubMed ID: 2178928
[TBL] [Abstract][Full Text] [Related]
22. Identification of conserved and variable regions in the envelope glycoprotein sequences of two feline immunodeficiency viruses isolated in Zurich, Switzerland.
Morikawa S; Lutz H; Aubert A; Bishop DH
Virus Res; 1991 Sep; 21(1):53-63. PubMed ID: 1660215
[TBL] [Abstract][Full Text] [Related]
23. The genome of feline immunodeficiency virus.
Miyazawa T; Tomonaga K; Kawaguchi Y; Mikami T
Arch Virol; 1994; 134(3-4):221-34. PubMed ID: 8129613
[TBL] [Abstract][Full Text] [Related]
24. Feline immunodeficiency virus gene expression: analysis of the RNA splicing pattern and the monocistronic rev mRNA.
Tomonaga K; Shin YS; Fukasawa M; Miyazawa T; Adachi A; Mikami T
J Gen Virol; 1993 Nov; 74 ( Pt 11)():2409-17. PubMed ID: 8245856
[TBL] [Abstract][Full Text] [Related]
25. The VP16 transcription activation domain is functional when targeted to a promoter-proximal RNA sequence.
Tiley LS; Madore SJ; Malim MH; Cullen BR
Genes Dev; 1992 Nov; 6(11):2077-87. PubMed ID: 1427073
[TBL] [Abstract][Full Text] [Related]
26. Functional comparison of transactivation by simian immunodeficiency virus from rhesus macaques and human immunodeficiency virus type 1.
Viglianti GA; Mullins JI
J Virol; 1988 Dec; 62(12):4523-32. PubMed ID: 2846868
[TBL] [Abstract][Full Text] [Related]
27. High level expression of the envelope glycoproteins of the human immunodeficiency virus type I in presence of rev gene using helper-independent adenovirus type 7 recombinants.
Chanda PK; Natuk RJ; Mason BB; Bhat BM; Greenberg L; Dheer SK; Molnar-Kimber KL; Mizutani S; Lubeck MD; Davis AR
Virology; 1990 Apr; 175(2):535-47. PubMed ID: 2183470
[TBL] [Abstract][Full Text] [Related]
28. The C/EBP site in the feline immunodeficiency virus (FIV) long terminal repeat (LTR) is necessary for its efficient replication and is also involved in the inhibition of FIV LTR-directed gene expression by pseudorabies virus ICP4.
Kawaguchi Y; Tomonaga K; Maeda K; Ono M; Miyazawa T; Kohmoto M; Tohya Y; Mikami T
Virology; 1995 Apr; 208(2):492-9. PubMed ID: 7747422
[TBL] [Abstract][Full Text] [Related]
29. Efficiency of reinitiation of translation on human immunodeficiency virus type 1 mRNAs is determined by the length of the upstream open reading frame and by intercistronic distance.
Luukkonen BG; Tan W; Schwartz S
J Virol; 1995 Jul; 69(7):4086-94. PubMed ID: 7769666
[TBL] [Abstract][Full Text] [Related]
30. Minimum requirements for efficient transduction of dividing and nondividing cells by feline immunodeficiency virus vectors.
Johnston JC; Gasmi M; Lim LE; Elder JH; Yee JK; Jolly DJ; Campbell KP; Davidson BL; Sauter SL
J Virol; 1999 Jun; 73(6):4991-5000. PubMed ID: 10233961
[TBL] [Abstract][Full Text] [Related]
31. A transdominant tat mutant that inhibits tat-induced gene expression from the human immunodeficiency virus long terminal repeat.
Pearson L; Garcia J; Wu F; Modesti N; Nelson J; Gaynor R
Proc Natl Acad Sci U S A; 1990 Jul; 87(13):5079-83. PubMed ID: 2195547
[TBL] [Abstract][Full Text] [Related]
32. Activation of transcription by HIV-1 Tat protein tethered to nascent RNA through another protein.
Southgate C; Zapp ML; Green MR
Nature; 1990 Jun; 345(6276):640-2. PubMed ID: 2190099
[TBL] [Abstract][Full Text] [Related]
33. Replication of HIV type 1 in rabbit cell lines is not limited by deficiencies in tat, rev, or long terminal repeat function.
Cho S; Kindt TJ; Zhao TM; Sawasdikosol S; Hague BF
AIDS Res Hum Retroviruses; 1995 Dec; 11(12):1487-93. PubMed ID: 8679293
[TBL] [Abstract][Full Text] [Related]
34. Identification of the nuclear and nucleolar localization signals of the Feline immunodeficiency virus Rev protein.
Marchand C; Lemay G; Archambault D
Virus Res; 2020 Dec; 290():198153. PubMed ID: 33010374
[TBL] [Abstract][Full Text] [Related]
35. Feline immunodeficiency virus ORF-Ais required for virus particle formation and virus infectivity.
Gemeniano MC; Sawai ET; Leutenegger CM; Sparger EE
J Virol; 2003 Aug; 77(16):8819-30. PubMed ID: 12885901
[TBL] [Abstract][Full Text] [Related]
36. Posttranscriptional effector domains in the Rev proteins of feline immunodeficiency virus and equine infectious anemia virus.
Mancuso VA; Hope TJ; Zhu L; Derse D; Phillips T; Parslow TG
J Virol; 1994 Mar; 68(3):1998-2001. PubMed ID: 8107262
[TBL] [Abstract][Full Text] [Related]
37. Study of the HIV-2 Env cytoplasmic tail variability and its impact on Tat, Rev and Nef.
Bakouche N; Vandenbroucke AT; Goubau P; Ruelle J
PLoS One; 2013; 8(11):e79129. PubMed ID: 24223892
[TBL] [Abstract][Full Text] [Related]
38. Regulation of expression of human immunodeficiency virus.
Pavlakis GN; Felber BK
New Biol; 1990 Jan; 2(1):20-31. PubMed ID: 2078551
[TBL] [Abstract][Full Text] [Related]
39. Regulation of HIV-1 envelope protein synthesis by Tat and Rev in 293 cells.
Natarajan V; Radjendirane V; Salzman NP
Virology; 1993 Sep; 196(1):122-9. PubMed ID: 8356789
[TBL] [Abstract][Full Text] [Related]
40. Two species of Rev proteins, with distinct N termini, are expressed by caprine arthritis encephalitis virus.
Gazit A; Mashiah P; Kalinski H; Gast A; Rosin-Abersfeld R; Tronick SR; Yaniv A
J Virol; 1996 Apr; 70(4):2674-7. PubMed ID: 8642706
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
